Edit
Precision Medicine Group
https://www.precisionmedicinegrp.com/Last activity: 12.03.2026
Active
With the discipline of precision medicine as our foundation, Precision Medicine Group leverages specialized expertise to move science closer to health.
Location: United States, Maryland, Bethesda
Total raised: $275M
Investors 4
| Date | Name | Website |
| - | Vida Ventu... | vidaventur... |
| - | Oak Invest... | oakvc.com |
| - | TPG | tpg.com |
| 17.07.2021 | Berkshire ... | berkshirep... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.12.2017 | - | $275M | - |
Mentions in press and media 21
| Date | Title | Description |
| 12.03.2026 | Precision for Medicine Continues Asia-Pacific Expansion with Opening of Japan Office | New Tokyo office strengthens local partnerships, regulatory alignment and global integrations in the world's third largest pharmaceutical market BETHESDA, Md., March 12, 2026 /PRNewswire/ -- Precision for Medicine (Precision), a global lead... |
| 30.12.2024 | Berkshire Partners Announces that Sharlyn Musslewhite and Whitney Kelly are Named in GrowthCap’s 2024 List: “Top Women Leaders in Growth Investing” | Leaders recognized for their remarkable experience with both colleagues and portfolio company leadership BOSTON--(BUSINESS WIRE)--Berkshire Partners is pleased to announce Managing Director Sharlyn Musslewhite and Principal Whitney Kelly ha... |
| 30.12.2024 | Berkshire Partners Announces Two New Managing Directors | BOSTON – December 17, 2024 – Berkshire Partners, a growth-oriented investor in private and public markets, announced today that Liz Bride and Whitney Kelly have been appointed Managing Directors of the firm. Liz Bride joined the firm in 201... |
| 02.10.2024 | Pfizer's Strategic Shift: Selling Haleon Shares and Precision Medicine's New Leadership | In the ever-evolving landscape of pharmaceuticals, companies often pivot to stay ahead. Pfizer is making waves again. The pharmaceutical giant has announced a significant move: selling its stake in Haleon, the maker of Sensodyne, for a stag... |
| 01.10.2024 | Precision Medicine Group Welcomes Margaret Keegan as CEO | - |
| 01.10.2024 | Precision Medicine Group Welcomes Margaret Keegan as CEO | -- Founding CEO Mark Clein named Executive Chairman; Mr. Clein and co-founder Ethan Leder to continue as Board Directors -- BETHESDA, Md., Oct. 1, 2024 /PRNewswire/ -- Precision Medicine Group (Precision), a leading next-generation provider... |
| 13.03.2023 | Precision Medicine Group Appoints John Hubbard, PhD, as Board of Directors Chair | BETHESDA, Md., March 13, 2023 /PRNewswire/ -- Precision Medicine Group (PMG), a leading next-generation provider of drug development and commercialization services, today announced the appointment of John Hubbard, PhD, as Chairman of its Bo... |
| 12.11.2019 | Should employers take a chance on little-known Embarc to pay for gene therapy? | The promise of curing deadly diseases by administering a one-time therapy that rewrites a patient’s genetic code is no longer the stuff of science fiction. Yet this innovation comes with a steep price tag. Zolgensma, approved for spinal mus... |
| 08.11.2019 | Cambridge companies recognised at industry leading OBN Awards 2019 event | Cambridge companies recognised at industry leading OBN Awards 2019 event 08-11-2019 Cambridge Network members Bicycle Therapeutics and Endomag have been honoured at the 2019 OBN Awards, which celebrate the best of UK life sciences. OBN (UK)... |
| 24.04.2019 | Early treatment with gene therapy: lessons from vaccines | The concept of modifying the human genome to treat or cure disease was once the stuff of science fiction. Today there are products on the market to do just that. This amazing leap has come with a hefty price tag. Currently marketed gene the... |
Show more